Product information and disease descriptionProduct descriptionProduct information
Access and distribution
5 evidence topics · 5 sources
Current access through clinical trials and the open-label extension
Manufacturing: contract manufacturers in Europe
Commercial supply and technology transfer
Commercial organization and distribution capabilities
Patent protection
Expanded access program, HCPCS code, distribution channel, and REMS
No evidence found.